SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $93 | -94.8% | 811 | -93.8% | 0.02% | -97.1% |
| Q1 2023 | $1,792 | -99.9% | 13,000 | -48.0% | 0.77% | -20.1% |
| Q4 2021 | $2,251,000 | +15.8% | 25,000 | 0.0% | 0.96% | +153.7% |
| Q2 2021 | $1,944,000 | +30.4% | 25,000 | +25.0% | 0.38% | -30.1% |
| Q1 2021 | $1,491,000 | -48.6% | 20,000 | -11.1% | 0.54% | -49.5% |
| Q4 2019 | $2,903,000 | +156.9% | 22,500 | +50.0% | 1.08% | +89.1% |
| Q3 2019 | $1,130,000 | -73.0% | 15,000 | -45.5% | 0.57% | -43.6% |
| Q2 2019 | $4,179,000 | +133.7% | 27,500 | +83.3% | 1.01% | +53.4% |
| Q1 2019 | $1,788,000 | -18.1% | 15,000 | -25.0% | 0.66% | -44.0% |
| Q4 2018 | $2,183,000 | -45.9% | 20,000 | -20.0% | 1.18% | -18.3% |
| Q3 2018 | $4,038,000 | +1.8% | 25,000 | -16.7% | 1.44% | -5.5% |
| Q2 2018 | $3,965,000 | +78.4% | 30,000 | 0.0% | 1.52% | +47.1% |
| Q1 2018 | $2,223,000 | +33.2% | 30,000 | 0.0% | 1.04% | +67.5% |
| Q4 2017 | $1,669,000 | – | 30,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |